// App-Quantinova.ai

3568 : Delta-tocotrienol and simvastatin induce cytotoxicity and synergy in BRAF mutant SK-MEL-28 but not in wild type BRAF SK-MEL-2 melanoma cancer cells

Researchers

Presenter

  • Kelley Cross

Principal Investigators

  • Victoria Palau

  • Marianne Brannon

  • Janet Lightner

  • Megan Dycus

  • William Stone

  • Koyamangalath Krishnan

Medical Centers

  • East Tennessee State University, Johnson City, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Simvastatin

  • Vemurafenib

  • Dabrafenib Mesylate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved